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Abstract
White spot syndrome virus (WSSV), a large enveloped DNA virus, can cause the most serious viral disease in shrimp and has
a wide host range among crustaceans. In this study, we identified a surface protein, named glucose transporter 1 (Glut1),
which could also interact with WSSV envelope protein, VP53A. Sequence analysis revealed that Glut1 is a member of a large
superfamily of transporters and that it is most closely related to evolutionary branches of this superfamily, branches that
function to transport this sugar. Tissue tropism analysis showed that Glut1 was constitutive and highly expressed in almost
all organs. Glut1’s localization in shrimp cells was further verified and so was its interaction with Penaeus monodon chitin-
binding protein (PmCBP), which was itself identified to interact with an envelope protein complex formed by 11 WSSV
envelope proteins. In vitro and in vivo neutralization experiments using synthetic peptide contained WSSV binding domain
(WBD) showed that the WBD peptide could inhibit WSSV infection in primary cultured hemocytes and delay the mortality in
shrimps challenged with WSSV. These findings have important implications for our understanding of WSSV entry.
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Introduction
White spot syndrome virus (WSSV) is the causative agent of a
disease that has led to severe mortality rates of cultured shrimps in
Taiwan and many other countries. WSSV, a kind of large
enveloped DNA virus, has a wide host range among crustaceans
[1,2]. After the sequences of the WSSV genome for various isolates
have been revealed, research regarding protein-protein interaction
between shrimp and virus, shrimp itself or virus itself are now
taken into consideration [3,4,5]. Above all, the interaction
between the receptor/co-receptor of the host cell and the
receptor-binding protein of virus is highly remarkable because
binding and entry of viruses requires specific interactions between
the structural proteins on the virus and cell surface receptor
complexes on target cells. The molecules to which viruses bind
constitute a diverse collection of cellular proteins, carbohydrates,
and lipids. They differ from one virus to the next, and they range
from abundant and ubiquitous to rare and cell specific [6]. To
date, more than one shrimp protein was supposed to participate in
WSSV infection [7,8,9,10]. However, there is no further evidence
to verify whether these host proteins cooperate with each other to
mediate virus infection or the exact functions these proteins play
while infecting. We still can not precisely illustrate the process how
WSSV enters the host cell.
Key issues in virology have been identification of cell-surface
virus receptor, determination of receptor expression patterns, and
elucidation of the effects of infection on the normal functions of the
molecules [11]. In the previous study, a host membrane protein,
Penaeus monodon chitin-binding protein (PmCBP), which can
specifically interact with WSSV envelope protein VP53A, was
identified [8]. The data showed that in vivo neutralization using
recombinant VP53A and PmCBP can reduce and delay mortality
upon WSSV challenge, indicating that PmCBP was involved in
WSSV infection. Moreover, besides VP53A, PmCBP was found to
at least interact with ten other envelope proteins (VP24, VP110,
VP53B, VP337, VP32, VP124, VP41A, VP51B, VP60A and
VP39B) [10]. These findings suggest that the process of WSSV
infection was extremely complex and that there must still be an
unknown number of proteins which play a part.
To continue to unravel the process of WSSV entry and the
formation of entry-related complexes, we identified a P. monodon
and Litopenaeus vannamei surface protein, named glucose transporter
1 (Glut1), which could also interact with VP53A. Glut1’s
localization in shrimp cells was further characterized and its
interaction with PmCBP was also verified.
Results
Identification of glucose transporter 1 (Glut1) in shrimps
To identify shrimp proteins that bind WSSV envelope protein
VP53A, we performed a yeast two-hybrid screen with VP53A as
bait and the library was constructed from shrimp Penaeus monodon
[8]. In the previous study, the screening of the cDNA library led to
isolate a membrane protein named P. monodon chitin-binding
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clone Y455 which coded 106 amino acids was identified. Yeast
expressing BD-contained VP53A and AD-contained Y455 formed
colonies on SD medium lacking leucine (Leu), tryptophan (Trp),
histidine (His), and adenine (Ade). The results suggested strongly
that, in yeast, VP53A and Y455 interact, and that examination of
this interaction under different conditions was warranted. The
interaction between VP53A and the gene product form clone
Y455 was further confirmed by far western blotting. As shown in
Fig. 1B, the gene product from clone Y455 containing HA tag can
be specific detected with anti-HA antibody. After incubating with
recombinant VP53A, the gene product can be detected with anti-
VP53A antibody. The result indicated that VP53A interacts with
the gene product of clone Y455.
Because the clone Y455 only contained the last 106 amino acids
of the 39 terminus of an unknown gene, the 59 terminus of this
gene was obtained by the method of rapid amplification of the
cDNA 59 end (59 RACE). In this study, Litopenaeus vannamei Glut1,
not P. monodon Glut1, was fully sequenced because L. vannamei was
the experimental species in the further study of gene analysis. Fig. 2
shows the predicted amino acid sequence and major structural
features of the full-length of clone Y455. The open reading frame
(ORF) encodes a protein of 569 amino acids with a theoretical size
of about 63 kDa (and a predicted isoelectric point of 4.96). The
nucleotide sequence surrounding the methionine start codon
(ACGATGG) of the predicted protein conformed to the Kozak
rule of an efficient context for eukaryotic translation initiation
[12,13]. A polyadenylation signal (AATAAA) was located 193 bp
downstream of the translational stop codon. The deduced amino
acid sequence of the ORF has five NX(S/T) sites for potential N-
linked glycosylation. The Kyte-Doolittle program [14] of this ORF
suggested the presence of 12 hydrophobic potential transmem-
brane (TM) sequences, consistent with its possible presence in
cellular membranes. The protein contains several dileucines,
which may be required for endocytosis [15]. Because the last 106
amino acid interacting with WSSV VP53A contained the short
extracellular segment KYSY between TM11 and TM12, a
putative WSSV binding domain (WBD) was suggested to locate
at this region.
Sequence analysis using NCBI BLAST program (http://www.
ncbi.nlm.nih.gov/) revealed that the gene product of full-length of
Y455 showed strong homology to a MFS transporter of Aedes
aegypti (GenBank accession no.: XP_001662291), a cation
transporter protein of Drosophila grimshawi (GenBank accession
no.: XP_001996245), an organic cation transporter protein of
Harpegnathos saltator (GenBank accession no.: EFN86109), an
organic cation transporter of Apis mellifera (GenBank accession
no.: XP_395856), an organic cation transporter of Pediculus
humanus corporis (GenBank accession no.: XP_002425801) and an
organic cation transporter 1 of Camponotus floridanus (GenBank
accession no.: EFN71065). Those proteins were categorized to a
member of a large superfamily of transporters, major facilitator
superfamily (MFS), which generally contain 12 hydrophobic TM
sequences [16]. The MFS transporters have been classified into
187 evolutionary branches or subgroups that transport distinct
categories of solutes. The MFS signature sequence, which occurs
in the hydrophilic loop that separates TM2 and TM3, is the most
highly conserved sequence in this transporter superfamily [16,17].
Analyzing the deduced amino acid sequence of the ORF, the MFS
signature sequence was found TM2 and TM3 as in Fig. 2. It was
strongly confirmed that the gene product of full-length of Y455 is a
member of MFS transporter and it is most closely related to the
sugar porter (SP) family consisting over 133 sequenced members
derived from bacteria, archaea and eukarya.
Fig. 3 showed the hypothetical model for the structure of the
gene product of full-length of Y455. As reviewed in the paper of
glucose transporter [18], the common features revealed by
sequence alignment and analysis of the glucose transporters
include 12 predicted TM sequences arranged so that both the N-
and C-termini are at the cytoplasmic surface. There are large
loops between TM1 and TM2 and between helices TM6 and
TM7. The large loop between TM6 and TM7 divides the
structure into two halves, the N-terminal domain and the C-
terminal domain. Conserved motifs in the glucose transporters
include GR(R/K) between TM2 and TM3 in the N-terminal half,
and correspondingly between TM8 and TM9 in the C-terminal
half. Similarly, EXXXXXXR occurs between TM4 and TM5 in
the N-terminal half and correspondingly between TM10 and
TM11 in the C-terminal half. The N-linked glycosylation can
occur in the extracellular loop between TM1 and TM2. It almost
completely matched the features of glucose transporter. Thus, the
gene product of full-length of Y455 was named as glucose
transporter 1 (Glut1).
Tissue tropism and expression pattern of Glut1
RT-PCR was used to reveal the tissue tropism of Glut1. Glut1
was expressed in almost all organs including the pleopod, gill,
stomach, midgut, heart, lymphoid organ, nervous tissue, hepato-
pancreas, and hemolymph (Fig. 4).
Figure 1. VP53A interacted with Y455 clone in yeast. (A) Yeast
representing protein-protein interactions grew on high-stringency
(–Leu/–Trp/–His/–Ade) medium. Plasmids used in this figure are
described in the Materials and Methods. The blue signal in image was
due to the presence of X-a-Gal. (B) Far western blot. Upper image: the
yeast lysates were transferred on PVDF membrane and then detected
with anti-HA antibody. Lower image: the yeast lysates were transferred
on PVDF membrane, incubated with recombinant VP53A and the
detected with anti-VP53A antibody. The yeast transformed with
pGADT7-Rec only was set as control.
doi:10.1371/journal.pone.0033216.g001
A Receptor for WSSV Is a Transporter
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33216Figure 2. Primary structure of Y455 (Glut1) and major structural features. The gene product of full-length of Glut1 contains 569 amino acids
with 12 hydrophobic potential TM sequences. TM sequences are identified by the Kyte-Doolittle algorithm (Kyte and Doolittle, 1982) and are
indicated by underlining the amino acid sequence. Signature sequences for MFS transporter are boxed. Potential N-linked glycosylation sites are
shown in shaded boxes. The putative WSSV binding domain (WBD) between TM11 and TM12 is shown in bold font.
doi:10.1371/journal.pone.0033216.g002
A Receptor for WSSV Is a Transporter
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The partial Glut1 gene, the extracellular region between TM1
and TM2, was expressed in E. coli as a 66His-tagged fusion
protein. In the purification process of partial Glut1, after induction
with IPTG at 37uC, the SDS-PAGE result showed that a band
(about 14 kDa) corresponding to the Glut1-66His fusion protein
was observed in the induced bacterium (Fig. 5A, lane 2). No
protein was found at the same position in the non-induced control
(Fig. 5A, lane 1). The data indicated that the partial Glut1 gene was
expressed and a purified Glut1-66His partial fusion protein was
obtained (Fig. 5A, lane 3).
Western blotting was performed to detect the Glut1 in L.
vannamei. Owing to the fact that Glut1 is ubiquitous in a shrimp’s
body, heart was selected to be tested because it can be easily
extracted in buffer. As shown in Fig. 5B, an obvious band about
68 kDa was only detected with Glut1 antibody. No signal was
observed in the heart cells treated with rabbit pre-immune
antiserum. It indicated that the real molecular weight of Glut1 in
shrimp tissue was 68 kDa. It was larger than the theoretical size
(63 kDa) owing to the protein modification.
Cellular localization of Glut1
Since Glut1 was supposed to be a transporter protein and
must be located on the cell surface, hemocytes were applied to
identify the speculation in vivo. The hemocyte cells withdrawn
from L. vannamei were fixed, treated with rabbit anti-Glut1
antibody, and analyzed by confocal microscopy. As shown in
Fig. 6A, strong fluorescent signals from Glut1 were observed in
the plasma membrane. No fluorescent signal was observed in
Figure 3. Hypothetcal model for the structure of the gene product of full-length of Y455 (Glut1). The protein was predicted to contain
12 transmembrane (TM) sequences (TM1-12), with both the N- and C-termini intracellularly disposed. N-linked glycosylation can occur in the
extracellular loop between TM1 and TM2 as shown. Conserved amino acids are indicated by the appropriate single-letter code; filled circles indicate
conservative substitutions. The extracellular portion between TM1 and TM2 was selected to produce the recombinant protein to generate antibody
and analyze the protein-protein interaction.
doi:10.1371/journal.pone.0033216.g003
Figure 4. Tissue tropism analysis of Glut1. Lane 1–9: PCR amplified
Glut1 and a-actin fragments in pleopod, gill, stomach, midgut, heart,
lymphoid organ, nervous tissue, hepatopancreas, and hemolymph. C:
PCR reaction control which is set up in the same way as the
experimental PCRs, but without template DNA added.
doi:10.1371/journal.pone.0033216.g004
Figure 5. Recombinant expression in E. coli purification and
western blot of shrimp Glut1. (A) SDS-PAGE of expressed and
purified of partial protein. Lanes M, pre-stained molecular weight
marker; 1, non-induced; 2, induced; 3, purified Glut1-66His partial
fusion protein. (B) SDS-PAGE and western blotting of Glut1 in heart
tissue lysate. Lanes M, pre-stained molecular weight marker; lane 1,
coomassie blue stain; lane 2: heart tissue was incubated with rabbit pre-
immune antiserum; lane 3: heart tissue was incubated with anti-Glut1
antibody. Glut1 was indicated with arrowhead.
doi:10.1371/journal.pone.0033216.g005
A Receptor for WSSV Is a Transporter
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(Fig. 6B). Clearly, this confirmed that Glut1 was a membrane
protein.
Glut1 interacted with PmCBP
Since the interaction between VP53A and PmCBP has
already been revealed [8], the next question, whether Glut1 could
interact with PmCBP, was taken into consideration. To confirm
this, we carried out an in vitro far western blot using the
extracellular portion of Glut1 and also the extracellular portion
of PmCBP. The schematic diagram of Glut1 and PmCBP is
shown in Fig. 7A. As shown in Fig. 7B, anti-Glut1 antibody could
capture Glut1 but not PmCBP, and anti-PmCBP antibody could
capture PmCBP but not Glut1. It indicated that the specificity of
anti-Glut1 and anti-PmCBP antibodies were reliable. In the far
western experiments (Fig. 7C), the PmCBP incubated with
recombinant Glut1 could be recognized by anti-Glut1 antibody,
and the Glut1 incubated with recombinant PmCBP could be
recognized by anti-PmCBP antibody. The result strongly suggest-
ed that Glut1 could interact with PmCBP at both of their
extracellular portions.
In vitro and in vivo neutralization
The neutralization experiments were performed in vitro and in
vivo to identify whether the WBD (Fig. 2) on Glut1 can bind to
WSSV and then plays important roles in WSSV infection. Because
the protein with many transmembrane regions was difficult to
produce and purify, the synthetic peptides, LSKYSYSL, contain-
ing WBD was applied in this study. The expression of WSSV
immediate early gene ie1 was used as WSSV infection indicator
because ie1 could be detected at 2–4 h post-infection [19,20]. EF1-
a was set as experiment control [21]. Because the stable shrimp
cell line for WSSV infection assay is lacking, the in vitro
neutralization experiment was performed with primary cultured
hemocytes firstly to check the virus binding ability of WBD. Due to
the limitation of primary culture, the sampling times of the in vitro
neutralization experiment was limited in 20 h. In Fig. 8A, the
result of RT-PCR showed that WSSV infection can be detected in
hemocytes from 6 h after infection. However, the expression of
WSSV ie1 can not be detected in the cells infected with WSSV
treated with WSD peptides. The result clearly indicated that the
WBD peptide can bind to WSSV, and then inhibit WSSV enter
hemocytes.
The further neutralization experiment was performed in vivo in
shrimps. As shown in Fig. 8B, the mortality increased steadily from
3.5 day to 10.5 day in the group challenged with WSSV (positive
control). Although the mortality in the group challenged with
WSSV plus WBD peptide (10 mg/g shrimp) was similar to positive
control group, the mortality in the groups challenged with WSSV
plus WBD peptide (20 mg/g shrimp) were lower than WSSV
infection groups. IQ2000 WSSV Detection and Prevention
System confirmed that shrimp mortality was due to WSSV
infection (data not shown). The result in this experiment indicated
that the WBD peptide can delay the mortality in shrimps upon
WSSV challenge.
Discussion
To infect a target cell, a virion proceeds through a multistep
entry process, during which each step is preprogrammed and
tightly regulated in time and space [6]. Considerable progress has
been made in determining the mechanisms of cell entry used by
enveloped RNA viruses, but less is known about this process for
enveloped DNA viruses. RNA viruses typically have a single
transmembrane (TM) glycoprotein that undergoes a conforma-
tional transition triggered by receptor recognition or low pH,
leading to the insertion of a fusion peptide into the plasma
membrane or the membrane of an endocytic vesicle [22,23].
Differing from RNA viruses, the basic fusion machinery of the
Herpesviridae, a family of large enveloped DNA viruses, includes
three glycoproteins as well as subfamily-specific receptor binding
proteins [24]. Eight TM proteins were found to be required for
entry of vaccinia virus (VACV) [25]. It indicated that the
enveloped DNA viruses may utilize a protein complex to deal
with virus entry.
To date, it is not very clear how white spot syndrome virus
(WSSV), also a kind of large enveloped DNA virus, enters the host
cell. In our previous study, Penaeus monodon chitin-binding protein
(PmCBP), a cell membrane protein, was found to at least interact
with eleven envelope proteins (VP24, VP32, VP39B, VP41A,
VP53A, VP53B, VP51B, VP60A, VP110, VP124 and VP337).
The neutralization experiments only with PmCBP or VP53A
significantly, but incompletely, blocked the WSSV infection [10].
Figure 6. Cellular localizations of Glut1 in L. vannamei hemocytes by confocal microscopy. (A) Hemocytes were treated with rabbit anti-
Glut1 antibody. (B) Hemocytes were treated with rabbit pre-immune antiserum. Scale bar: 7.5 mm.
doi:10.1371/journal.pone.0033216.g006
A Receptor for WSSV Is a Transporter
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dealing with WSSV entry, similar to the herpesvirus and vaccinia
virus. Our result did not exclude the possibility that additional
viral and/or host proteins participate in the virus entry complex.
Thus, in this study, another host cell membrane protein, glucose
transporter 1 (Glut1), was screened and identified to partake in the
complex. The results of Y-2-H and far western blot firmly
suggested that Glut1 could both interact with VP53A and
PmCBP. We speculate that host cell membrane proteins Glut1
and PmCBP may form a heterodimer structure which could
interact with the WSSV envelope complex formed by the eleven
envelope proteins.
Transporters could be the receptors for some viruses. Recent
studies have determined that glucose transporter 1 (GLUT-1) is
required in the entry of human T-cell lymphotropic viruses
(HTLVs). Human Cytomegalovirus activates glucose transporter 4
expression in mammalian cells to increase glucose uptake during
infection [26]. For HTLV-1, GLUT-1 facilitates entry at a step
after the initial attachment to the target cell [27]. The cell surface
receptor FLVCR for feline leukemia virus C (FeLV-C) is identified
as a member of the major facilitator superfamily (MFS) and
demonstrated to export cytoplasmic heme [17,28]. Similarly, cell-
surface receptors for gibbon ape leukemia virus (Glvr-1) and
murine amphotropic retrovirus (Ram-1) are inducible sodium-
dependent phosphate symporters [11]. It indicates that some
retroviruses utilize related transporters for cell entry, and the
molecule the transporter transports is important for cell survival.
Although WSSV is not classified to Retroviridae and the precise role
of Glut1 is still unknown, by reviewing the studies of retroviruses,
we can speculate that the biological role of Glut1 must be very
important and the cell death after WSSV infection must be in
connection with Glut1.
Tissue tropism analysis by RT-PCR showed that Glut1 was
constitutive and highly expressed in pleopod, gill, stomach,
midgut, heart, lymphoid organ, nervous tissue, hepatopancreas,
and hemolymph (Fig. 4). Review in the research about
histopathology and tissue tropism after WSSV infection, the virus
mainly infects cells in tissues of ectodermal (cuticular epidermis,
fore- and hindgut, gills, and nervous tissue) and mesodermal
(lymphoid organ, antennal gland, connective tissue, and hemato-
poietic tissue) origins, whereas tissues of endodermal origin
(hepatopancreatic tubule epithelium and midgut epithelium) are
refractory to WSSV infection [29,30,31]. The tissue tropism of
Glut1 coincided with the tissues/organs which WSSV infected.
Besides, the research of FLVCR, the receptor for FeLV-C, has
already revealed that virus binding to the hematopoietic cells
Figure 7. Protein-protein interaction between Glut1 and PmCBP. (A) Schematic diagram of Glut1 and PmCBP. Transmenbrane regions are
shown in black boxes. The two solid lines indicated the portions of Glut1 and PmCBP for far western blot. The dot line indicated the portion
interacting with VP53A in the yeast-2-hybrid (Y-2-H) assay. (B) SDS-PAGE analysis of the specificity of anti-Glut1 and anti-PmCBP antibodies. The short
His tag containing protein purified from E. coli transformed with pET28 only was set as control. (C) Far western blot. Upper image: the recombinant
PmCBP was transferred on PVDF membrane and then incubated with recombinant Glut1. Lower image: the recombinant Glut1 was transferred on
PVDF membrane and then incubated with recombinant PmCBP.
doi:10.1371/journal.pone.0033216.g007
A Receptor for WSSV Is a Transporter
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affected [17]. In the late stage of WSSV infection, the amount of
hemocytes in the infected shrimp was dramatically reduced and
most tissues and organs showed massive multifocal necrosis [2].
Although the real function of Glut1 needs to be identified, we
propose that the transporter function of Glut1 might be affected by
WSSV and it leads to cell death.
In this study, the synthetic WSSV binding domain (WBD)
peptide can completely inhibit WSSV infection in vitro, but
promote only 25% survival rate of the shrimps which were
challenged by WSSV in the in vivo neutralization experiment. This
may be because the short synthetic peptide, without any
protection, might easily degrade in the animal body, or the partial
peptide can not present the protective effect due to its protein
conformation. Nevertheless, this result indeed provides a direction
to develop efficient antiviral strategies or therapeutic methods
using WBD.
In conclusion, a glucose transporter was revealed to join in the
virus entry complex. Up to the present, it is still unclear how and
when the protein complex forms. Our evidence does not exclude
the possibility that additional or alternative WSSV receptors and
receptor binding proteins occur. To date, besides PmCBP and
Glut1, more than one shrimp protein were supposed to mediate
WSSV infection [7,9]. The antiviral strategies on the basis of
interrupting the binding between shrimp and viral structural
proteins were applied to protect shrimps from virus infection
[32,33]. However, the results of this study provide directions for
further research.
Materials and Methods
Yeast two-hybrid (Y-2-H) assay
The plasmids, yeast strains and library construction kits used in
this experiment were all adopted from BD Matchmaker library
construction and screening kits (BD Biosciences Clontech). The
construction of bait plasmid pGBK-VP53A which contained the
GAL4 DNA-binding domain (BD) and the prey library which
contained activation domain (AD), and the screening procedure,
were as described in previous yeast two-hybrid assay [8]. In this
study, pGBK-VP53A and pGAD-PmCBP were regarded as
positive controls because their interaction has been confirmed.
Negative controls employed pGBKT7 only (BD) and pGADT7-
Rec only (AD). In this study, a positive clone Y455 was identified
and named as glucose transporter 1 (Glut1) after sequence
alignment. The interaction between VP53A and the gene product
form clone Y455 was confirmed by far western blotting and the
materials and methods for far western blotting in this study were
summarized in the later section.
Identification of the full-length Glut1 transcript
The sequences of the primers used in this study are shown in
Table 1. Total RNA isolation from the pleopod of Litopenaeus
vannamei was as described previously [8] with the following
modification: Briefly, for the isolation of total RNA, tissues
(100 mg) were homogenized in 1 ml TRIzol reagent (Invitrogen)
and then subjected to 2-propanol extraction and ethanol
precipitation according to the manufacturer’s recommendations.
Figure 8. In vitro and in vivo neutralization. (A) In vitro neutralization. Hemocytes infected with WSSV or WSSV plus WBD were collected to
identify virus infection. hpi: hours post-infection. (B) In vivo neutralization.
doi:10.1371/journal.pone.0033216.g008
A Receptor for WSSV Is a Transporter
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30 min at room temperature. The pellet was resuspended in
DEPC-water and quantified by spectrophotometer.
For the mapping of 59 terminus of the Glut1 transcript, the
reaction was determined by rapid amplification of the cDNA 59
end (59 RACE) using a commercial FirstChoiceH RLM-RACE kit
(Ambion) according to the instructions provided by the manufac-
turer. Briefly, an aliquot of 10 mg RNA was treated with Calf
Intestine Alkaline Phosphatase (CIP) at 37uC for 1 h to remove
free 59-phosphates from RNA and then re-extracted with phenol-
chloroform. The CIP-treated total RNA was then treated with
Tobacco Acid Pyrophosphatase (TAP) at 37uC for 1 h to remove
the cap structure from full-length mRNA, leaving a 59 mono-
phosphate. Then, a 45 base RNA adapter oligonucleotide supplied
by the kit was ligated to the 10 mg TAP-treated RNA. The first
strand cDNA was synthesized by the addition of 2 ml1 0 6RT
buffer, 2 ml random decamers, 4 ml dNTP mix, 1 ml RNase
inhibitor, and 1 ml M-MLV reverse transcriptase. The reaction
proceeded at 50uC for 1 h. The PCR for Glut1 was performed
using the primer Glut1-59RACE-sp1 and 59RACE Outer Primer
supplied by the kit for the 1-step PCR reaction and Glut1-
59RACE-sp2 and 59RACE Inner Primer supplied by the kit for the
2-step PCR reaction. The design of Glut1-59RACE-sp1/Glut1-
59RACE-sp2 primer set was based upon the obtained partial
cDNA sequence. Finally,LvGlu1-F/LvGlu1-R primer set (Table 1)
based upon the obtained full-length of Glut1 sequence to double-
check the accuracy of the Glut1 full-length sequence in L. vannamei.
The final products were characterized by subcloning and
sequencing, and the resulting sequences were then analyzed and
compared with other sequences. The sequence data was deposited
to GenBank (GenBank accession no.: HQ620544) and will be
released after the manuscript is accepted.
Tissue tropism analysis of Glut1 by RT-PCR
The organs – pleopod, gill, stomach, midgut, heart, lymphoid
organ, nervous tissue, hepatopancreas, and haemolymph - were
collected form L. vannamei. Total RNA was isolated as described in
Materials and methods. After RNA extraction, an aliquot of 10 mg
RNA was treated with 200 U of RNase-free DNase I (Roche) at
37uC for 30 min to remove any viral genomic DNA contamina-
tion and then re-extracted with phenol-chloroform. The DNase-
treated total RNA was denatured by heating at 65uC for 5 min in
10 ml DEPC-water containing 50 mM oligo dT-anchor primer
(Roche) and 1 ml1 0mM dNTP mix. The first strand cDNA was
synthesized by the addition of 2 ml1 0 6RT buffer, 2 ml 0.1 M
DTT, 4 ml 5 mM MgCl2,1ml 40 U RNaseOUT (Invitrogen), and
1 ml 200 U Superscript III reverse transcriptase (Invitrogen). The
reaction proceeded at 50uC for 50 min, and was terminated at
85uC for 5 min. Then, the cDNA was treated with 1 ml RNase H
to remove the RNA template from the cDNA.
Further, for the PCR reaction, the appropriate gene specific
primers, Glut1-RT-F/Glut1-RT-R for Glut1 and actin-RT-F/
antin-RT-R for b-actin (Table 1), were then used for PCR reaction.
The products were resolved in 1% agarose gel.
Recombinant Glut1 over-expression in Esherichia coli and
antiserum production
The DNA fragment encoding the extracellular portion between
TM1 and TM2 of Glut1 was amplified from shrimp L. vannamei
cDNA by PCR with the Glut1-BamHI -F1/Glut1-Hind-R1 primer
set (Table 1) for 40 cycles of denaturation at 94uC for 30 s,
annealing at 55uC for 30 s, extension at 72uC for 50 s, and then a
final extension at 72uC for 5 min. The PCR product was ligated to
pGEMH-T Easy (Promega) plasmid, and then the resultant
plasmid was sequenced by a commercial service (Mission Biotech
Co., Ltd, Taiwan). After confirming the sequence, the resultant
plasmid, pGEM-T-Glut1 was cleaved with BamHI and HindIIII,
and the amplified fragment was then cloned to pET28b+
(Novagen) at BamHI and HindIII sites. The resultant recombinant
plasmid, pET28-Glut1 was transformed into E. coli BL21 (DE3)
strain. E. coli BL21 (DE3) cells were cultured in LB medium with
25 mg/ml kanamycin and the protein was induced with 1 mM
isopropyl-b-D-thiogalactopyranoside (IPTG). The recombinant
Glut1 proteins tagged with 6 consecutive histidines (66His-tagged
Glut1) were purified using QIAexpressionist
TM nickel-nitrilotria-
cetic acid (Ni-NTA) metal-affinity chromatography (Qiagen)
according to the manufacturer’s recommendations. Finally, the
eluted protein was then concentrated using Amicon Ultra-15
centrifugal filters (Millipore) in PBS buffer and stored at 4uC for
further antiserum production and far western assay.
Table 1. List of primers used in this study.
Primer Sequence (59-39) Usage
Glut1-59RACE-sp1 GTAGCACAGACTCTGGCCGCTGA Glut1 59RACE
Glut1-59RACE-sp2 CAAGGAGTAACTGTACTTAGAC Glut1 59RACE
LvGlu1-F CAAGGGACCATCCGCTTGAACA L. vannamei Glut1 Gene cloning
LvGlu1-R GTCAGCCACACATGACGAAGCGG L. vannamei Glut1 Gene cloning
Glut1-RT-F AGGGGATAGGCACCATGCAGAC Glut1 RT-PCR
Gluct1-RT-R AAGGCGCGTCGCCTCGAAGG Glut1 RT-PCR
actin-RT-F CCGTCATCAGGGTGTGATGGT b-actin RT-PCR
actin-RT-R CCACGCTCAGTCATGATCTTCA b-actin RT-PCR
Glut1-BamHI-F1 ACTTGGATCCGATGTTCATAACCCTGACGCCCCC Recombinant protein producing
Glut1-Hind-R1 GCGAAAGCTTCTAGGCAGGCCGCCAGTCCTCGT Recombinant protein producing
wssv ie1-F GACTCTACAAATCTCTTTGCCA WSSV RT-PCR
wssv ie1-R CTACCTTTGCACCAATTGCTAG WSSV RT-PCR
EF1-a-F TGCCCTGGACAACATCGAGC EF1-aRT-PCR
EF1-a-R CGGGCACTGTTCCAATACCT EF1-aRT-PCR
doi:10.1371/journal.pone.0033216.t001
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with 250 mg proteins emulsified in complete Freund’s adjuvant.
Subsequent booster injections were carried out with 250 mg
protein emulsified in incomplete Freund’s adjuvant. The antise-
rum was collected after the antibody titer had peaked.
Yeast and shrimp tissue lysate
The yeast and heart tissue of shrimp were homogenized with
SDS lysis buffer (1% SDS, 0.01 M EDTA, 0.05 M Tris-HCl,
pH 8.0). The homogenate was centrifuged at 10,0006g for 5 min
and then supernatant containing the total protein was transferred
to new tube. The protein content was estimated using Bradford
assay.
Western blot analysis
For Western blotting analysis, yeast lysates, shrimp tissue lysate
or recombinant protein that had been separated in SDS-PAGE
was transferred onto a polyvinylidene difluoride (PVDF) mem-
brane (Millipore). Membranes were blocked in 5% skim milk
(Difco Laboratories) and 1% Tween20 in TBS buffer (50 mM
Tris-HCl and 0.5 M NaCl, pH 7.5). Immunodetection was
performed by incubation of the blot in a polyclonal rabbit anti-
HA antibody, anti-Glut1 antibody, anti-PmCBP antibody or pre-
immune antiserum diluted 1:2000 in TBST with 5% skim milk for
1 h at room temperature. Subsequently, goat anti-rabbit IgG
antibody conjugated with horseradish peroxidase (Jackson) was
used at a concentration of 1:5000 and detection was performed
with a Western Lightning
TM Plus-ECL (Bioman).
Cellular localization of Glut1 by indirect
immunofluorescence assay
Hemolymph was collected from the shrimp L. vannamei using a
syringe that contained cold anti-coagulant (27 mM sodium citrate,
336 mM NaCl, 115 mM glucose and 9 mM EDTA, pH 7.0). The
hemocytes were collected by centrifugation at 200 g at 4uC for
10 min, and then resuspended in 26Leibovitz’s L-15 (Invitrogen)
containing 20% fetal bovine serum (FBS), 2 g/l glucose, 100 UI/
ml penicillin, 100 mg/ml streptomycin and 2.4% NaCl. The
hemocytes were incubated at room temperature on microscope
slide for 2–3 hour, and monolayer cells formed. The monolayer
hemocytes were rinsed three times with 26L-15 medium, and then
were fixed in paraformaldehyde (4% in PBS) for 10 min at 4uC.
After fixation, the hemocytes were washed three times with PBS,
and incubated with blocking buffer (5% bovine serum albumin
and 5% normal goat serum in PBS) for 1 h at room temperature.
The hemocytes were then treated with polyclonal rabbit anti-
Glut1 antibody and preimmune serum (1:200 in blocking buffer)
for 1 h at room temperature. Next, the cells were washed three
times with PBST (0.2% Tween-20 in PBS) and reacted with Cy3-
conjugated goat anti-rabbit IgG antibodies (1:500 in PBS; Jackson
ImmunoResearch) at room temperature. Counterstaining of the
nucleus was performed with DAPI. After being washed three times
with PBST, the cover glasses were wet mounted and the
fluorescent signals were examined with a Leica TCS SP5 Confocal
Spectral Microscope Imaging System.
Far western blot analysis
In this study, different far western blot analyses were performed.
(1) In confirming the interaction between VP53A and the gene
product form clone Y455, the yeasts transformed with pGAD-
Y455 or pGADT7-Rec were separated by SDS-PAGE, trans-
ferred onto a PVDF membrane and renatured gradually at 4uC
overnight in HEPES buffer (20 mM HEPES, 100 mM NaCl,
1 mM EDTA, 1 mM dithiothreitol, 0.1% Tween20, 10%
glycerol, pH 7.5) containing 5% skim milk. To determine whether
VP53A interacts with the gene product form clone Y455, the blot
was incubated with another 0.5 mg probe recombinant VP53A
protein in incubation buffer (20 mM Tris/HCl, 150 mM NaCl,
0.05% Tween-20, 3% skim milk, pH7.5). Then the blot was
incubated in a polyclonal rabbit anti-VP53A antibody diluted
1:5000 in TBST with 5% skim milk for 1 h at room temperature.
Subsequently, goat anti-rabbit IgG antibody conjugated with
horseradish peroxidase (Jackson) was used at a concentration of
1:5000 and detection was performed with a Western Lightning
TM
Plus-ECL (Bioman). The production of recombinant VP53A and
the generation of polyclonal rabbit anti-VP53A antibody were as
mentioned in the previous studies [8,10]. In this experiment, the
yeast transformed with pGADT7-Rec only was set as control. (2)
In confirming the interaction between Glut1 and PmCBP,
recombinant proteins Glut1 or PmCBP containing His tag were
separated by SDS-PAGE, transferred onto a PVDF membrane
and also renatured gradually at 4uC overnight in HEPES buffer
containing 5% skim milk. To determine whether Glut1 interacts
with PmCBP, the blot was incubated with another 0.5 mg probe
recombinant PmCBP or Glut1 proteins in incubation buffer. Then
the blot was incubated in a polyclonal rabbit anti-PmCBP or anti-
Glut1 antibodies diluted 1:5000 in TBST with 5% skim milk for
1 h at room temperature. The further steps were as described
above. The production of recombinant PmCBP and the
generation of polyclonal rabbit anti-PmCBP antibody were as
mentioned in the previous study [10]. In this experiment, the short
His tag containing protein purified from E. coli transformed with
pET28 only was set as control.
In vitro neutralization
The peptide (LSKYSYSL) was synthesized by a manufacturer
(Seeing Bioscience Co., Ltd, Taiwan) with a purity of 75% and the
sequence was confirmed by mass spectrometry. The method of
hemocyte collection was as described earlier. WSSV (10
6 copies)
was incubated with synthetic WBD peptides or PBS, as a control
group, for 30 min at room temperture. The mixtures of peptides
and WSSV were then incubated with the hemocyte (4.0610
5 cells)
at 28uC in a 24-well microplate. After incubation for 2 h, 6 h and
20 h, haemocytes were washed with PBS and proceeded to RT-
PCR. The expression of WSSV immediate early gene ie1 was used
as WSSV infection indicator and EF1-a was set as control
(Table 1). The experiments were conducted at least 3 times with
both peptide-treated and control groups.
In vivo neutralization
This study was carried out by using invertebrate species L.
vannamei. According to the Guide for Animal Use Protocol of the
Institutional Animal Care and Use Committee (IACUC) of
National Taiwan Ocean University, ethics approval is not
required. The shrimp L. vannamei (body length, 561 cm; weight,
360.5 g) used in the experiment was obtained from the Aquatic
Animal Center, National Taiwan Ocean University. Shrimps were
acclimatized in the laboratory for about 1 week before the
experimentation. The experimental shrimps were then further
divided into four groups, with three replicates of 10,15 shrimps in
each group. The shrimps were injected as follows: group 1 with
WSSV (10
6 copies) as the positive control, group 2 with PBS as the
buffer negative control, group 3 with WSSV (10
6 copies) plus
WBD peptide (10 mg/g shrimp) and group 4 with WSSV (10
6
copies) plus WBD peptide (20 mg/g shrimp). The synthetic peptide
was mixed with virus at room temperature for 1 h and then
injected into the experimental shrimps. During the acclimatization
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commercial shrimp diet. The water conditions were kept at
2561uC and a salinity of 30%. During the experimental period,
the shrimp mortalities in every group were recorded 2 times a day.
Cumulative mortality was calculated and subjected to paired
sample t-test. Differences were considered significant at p,0.05.
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